Newton Webinar Series
Wednesday, May 13, 2020

Steve Finkbeiner, MD, PhD

Director, Center for Systems and Therapeutics

Steve Finkbeiner, MD, PhD, and his lab study brain cells to understand how they learn and remember, as well as what causes them to malfunction and die in diseases, such as Parkinson’s, Alzheimer’s, and Huntington’s disease.

In this webinar, Finkbeiner will explore ways to transform the traditional approach to science by leveraging expertise in robotics and artificial intelligence to build a “thinking microscope"—one that learns from the images it analyzes and designs its own experiments, improving the rigor and reproducibility of research, lowering costs, and accelerating the discovery of cures.

Bring your questions and curiosity and join us for a series of frank and unscripted interviews with some of the most creative minds in science today.


As the eyes of the world have turned upon the scientific community in the midst of the COVID-19 crisis, Gladstone’s researchers are part of an unprecedented effort to develop effective testing, explore potential therapeutics, and accelerate toward a vaccine as rapidly as possible. Meanwhile, our research in neurology, cardiology, and bioinformatics remains vitally important and continues to move forward in spite of physical constraints.

Details

Date
May 13, 2020
Time
12:00-1:00pm
Location
Zoom
Audience
Public
Contact(s)






The Newton Webinar Series is inspired by the story of Isaac Newton’s extraordinary intellectual output while in quarantine during the Great London Plague of 1665, and offers an alternative to all the news related to COVID-19. Each week, we will feature a conversation with Gladstone’s scientists and explore their moonshot ideas, how they approach their work, and what they think medicine may look like 10, 20, and 50 years from now.